Arcus Biosciences SG&A Expense (TTM) Analysis

Arcus Biosciences Inc (RCUS)

15.52 -0.89 (-5.42%) USD | NYSE | Jun 26, 10:47

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	119.00M
December 31, 2023	117.00M
September 30, 2023	116.00M
June 30, 2023	112.00M
March 31, 2023	110.00M
December 31, 2022	104.00M
September 30, 2022	99.01M
June 30, 2022	89.35M
March 31, 2022	80.18M
December 31, 2021	72.00M
September 30, 2021	62.37M
June 30, 2021	57.21M
March 31, 2021	51.81M

Date	Value
December 31, 2020	43.00M
September 30, 2020	36.21M
June 30, 2020	32.79M
March 31, 2020	27.27M
December 31, 2019	25.23M
September 30, 2019	22.25M
June 30, 2019	18.07M
March 31, 2019	15.61M
December 31, 2018	13.57M
September 30, 2018	12.40M
June 30, 2018	10.69M
March 31, 2018	9.069M
December 31, 2017	7.636M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

18.07M

Minimum

Jun 2019

119.00M

Maximum

Mar 2024

69.74M

Average

67.19M

Median

SG&A Expense (TTM) Benchmarks